RT @HospInnovations: Cost-effectiveness for ostechondral allograft transplantation is very high. Data is showing that acute graft costs are…
Cost-effectiveness for ostechondral allograft transplantation is very high. Data is showing that acute graft costs are offset by excellent long-term survival results. https://t.co/6qlE758YxM View our Fresh OC allograft portfolio at https://t.co/TPg89IANY
RT @TimSpaldingKnee: The best data in one place. Thanks @Profverdonk https://t.co/hoVQJnIhji
RT @TimSpaldingKnee: The best data in one place. Thanks @Profverdonk https://t.co/hoVQJnIhji
RT @TimSpaldingKnee: The best data in one place. Thanks @Profverdonk https://t.co/hoVQJnIhji
The best data in one place. Thanks @Profverdonk
RT @Profverdonk: Allografts in joint reconstruction: #ESSKA making a difference. The evidence behind the use of allografts. Join #EAI Europ…
RT @Profverdonk: Allografts in joint reconstruction: #ESSKA making a difference. The evidence behind the use of allografts. Join #EAI Europ…
RT @Profverdonk: Allografts in joint reconstruction: #ESSKA making a difference. The evidence behind the use of allografts. Join #EAI Europ…
RT @Profverdonk: Allografts in joint reconstruction: #ESSKA making a difference. The evidence behind the use of allografts. Join #EAI Europ…
Allografts in joint reconstruction: #ESSKA making a difference. The evidence behind the use of allografts. Join #EAI European allograft initiative to improve availability for our patients! In the correct indications of course!-) @EP_Belgium https://t.c